The National Comprehensive Cancer Network recently updated their patient guide to support stereotactic body radiation therapy (SBRT) for prostate cancer. The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 26 of the world’s leading cancer centers, is dedicated to improving the quality, efficiency, and effectiveness of care for patients with cancer. NCCN aims […]
Philadelphia CyberKnife presented three clinical outcomes research projects at the American College of Radiation Oncology’s 25th annual meeting from May 14 – 16 in Washington, D.C. American College of Radiation Oncology (ACRO) is the essential professional society for success in the day-to-day practice of radiation oncology. ACRO strives to ensure the highest quality care for […]
Greg Spurlock, President of Alliance Oncology, announced that Luther W. Brady M.D., Director of Medical Research at The CyberKnife Center of Philadelphia, was awarded George Washington University President’s Medal. “Everyone at Alliance Oncology would like to congratulate Dr. Brady on winning this prestigious award,” said Spurlock. “Dr. Brady has dedicated his life to the field […]
Philadelphia CyberKnife recently participated with NRG Oncology in the NRG-BR001 protocol, a Phase I Study of Stereotactic Body Radiotherapy for the Treatment of Multiple Metastases, and successfully completed their first patient treatment in May 2015. NRG Oncology is a non-profit research organization formed to conduct oncologic clinical research and to broadly disseminate study results for informing […]